In 2009, Moers et al. published the largest ever randomized controlled trial comparing paired kidneys that were either subjected to hypothermic machine perfusion (HMP) or cold storage (CS). This study included 336 kidney pairs that were randomized to either the HMP group or CS group.
Overall, they found that:
- HMP significantly reduced the risk of delayed graft function (DGF)
- Duration of DGF was shorter in the HMP group
- One-year graft survival was significantly higher in the HMP group
They concluded that hypothermic machine perfusion reduces the incidence of DGF as well as reducing the risk of graft failure in the first year, resulting in improved 1-year graft survival compared to kidneys preserved by static cold storage.
Read the full article here: https://www.nejm.org/doi/full/10.1056/NEJMoa0802289
Check out the most recent posts
David’s Transplant Journey
In this powerful video, we meet David, a liver recipient who shares his journey of needing a liver transplant. David speaks about the emotional and physical toll of waiting for a liver to become available, not knowing when or if he would receive that call. David takes...
Changing liver utilization and discard rates in clinical transplantation in the ex-vivo machine preservation era
A recent review article by Azizieh et al. focused on the implementation of ex-vivo machine preservation and how it might change the perception of organ acceptability. By focusing on machine perfusion, they explored the effects of the different modalities on outcomes...
Therapeutic Hypothermia or Hypothermic Machine Perfusion (HMP) which is best for Kidney Transplant Outcomes?
In 2023, Malinoski et al. published the results from a pragmatic, adaptive, prospective, randomized trial that was conducted between August 10, 2017, and May 21, 2020 involving six OPOs in the US. They sought to determine whether targeted mild hypothermia is as...
Business Wire—Organ Recovery Systems’ LifePort Liver Transporter Preserves First Livers for Transplant as Part of the PILOT Continued Access Study
We are proud to announce that the first livers have officially been transplanted using the LifePort®Liver Transporter as part of the PILOT™ Continued Access Study. The first livers preserved with the LLT under Continued Access were transplanted at University...